Showing results (211-220 of 258) with videos related to

Sort By:
Pageof 26
Journal of Fish Diseases|June 17, 2025
Streptococcus dysgalactiae From Farm-Raised Channel Catfish in Mississippi, USA, With Notes on Fish-Associated Group C S. dysgalactiaeSujita Balami, Lester H Khoo, Caitlin E Older, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Generating synthetic tau-PET scans in Alzheimer's disease from MRI, blood biomarkers and demographics with deep learningLinda Karlsson, Olof Strandberg, Ruben Smith, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 29, 2026
Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's diseaseJulie Lee, Emily Olafson, Balazs Toth, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 24, 2025
Plasma Alzheimer's disease biomarker relationships with incident abnormal amyloid PETPetrice M Cogswell, Heather J Wiste, Stephen D Weigand, et al.
Neurology|May 11, 2012
Neuro-QOL: brief measures of health-related quality of life for clinical research in neurologyD Cella, J-S Lai, C J Nowinski, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 7, 2023
Plasma Aβ42/Aβ40 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's diseaseRobert A Rissman, Oliver Langford, Rema Raman, et al.
The Journal of Prevention of Alzheimer'S Disease|October 25, 2022
Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task ForceD Angioni, J Delrieu, O Hansson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 16, 2024
Clinical validation of the PrecivityAD2 blood test: A mass spectrometry-based test with algorithm combining %p-tau217 and Aβ42/40 ratio to identify presence of brain amyloidMatthew R Meyer, Kristopher M Kirmess, Stephanie Eastwood, et al.
Brain : a Journal of Neurology|February 25, 2026
Modelling the temporal evolution of plasma p-tau217, amyloid PET, tau PET and cognitionPetrice M Cogswell, Emily S Lundt, Terry M Therneau, et al.
Nature Medicine|April 9, 2025
Plasma phospho-tau217 for Alzheimer's disease diagnosis in primary and secondary care using a fully automated platformSebastian Palmqvist, Noëlle Warmenhoven, Federica Anastasi, et al.
Pageof 26